Searchable abstracts of presentations at key conferences in endocrinology

ea0051p092 | Diabetes | BSPED2017

Description of the prevalence, demographics and service provision for children with autism or epilepsy in our type 1 diabetes clinic

Smith Chloe , Moran Maria , Ball Amy , Drew Josephine , Denvir Louise , Randell Tabitha , Sachdev Pooja

Background: Previous reports suggest that epilepsy and autism are more common in children with autoimmune diseases such as type 1 diabetes (T1D). While each condition is common in the general population, only small numbers of children have the two conditions together, so there is currently little coordinated support. We sought to describe the incidence in our own population.Methods: Retrospective review of the Diamond database and clinical notes for chil...

ea0085p10 | Bone | BSPED2022

Hypophosphatemic rickets as a key presenting feature of tyrosinemia type 1

Chandwani Manju , Usman Shehla , Law James , Denvir Louise , Sachdev Pooja , Randell Tabitha , Qureshi Isaque

Queen’s Medical Centre, Nottingham, United KingdomTyrosinemia type-1 is a rare autosomal recessive disorder. It usually presents in an acute form in early infancy. Rarely, it can also present as a chronic form with gradual onset. The key presenting features are failure to thrive, liver dysfunction and/or Fanconi syndrome. We present a perplexing case of a 2-year-old girl with tyrosinemia type-1, who initially presented with failure to thrive and hypophosphatemic rickets w...

ea0066oc5.1 | Oral Communications 5 | BSPED2019

Project to develop BSPED UK standardised guidelines for sex hormone priming and glucagon stimulation testing (GST) in children and adolescents

Wei Christina , Musson Pauline , Clayton Peter , Dattani Mehul , Randell Tabitha , Crowne Elizabeth C

Background: The GST is commonly used in children and adolescents for the diagnosis of growth hormone (GH) deficiency. Evidence supports the use of sex steroid priming to improve diagnostic accuracy in GH provocation tests. This project, undertaken on behalf of the BSPED Clinical Committee, aims to identify current practice and develop consensus in sex hormone priming and GST protocols for the development of standardised UK protocols.Method: (1) Audit of ...

ea0066oc5.6 | Oral Communications 5 | BSPED2019

Monitoring and long-term disease activity in children with X-linked hypophosphataemia on conventional therapy

Uday Suma , Shaw Nick , Mughal Zulf , Randell Tabitha , Hogler Wolfgang , Santos Rui , Padidela Raja

Background: Conventional treatment of X-linked hypophosphataemic rickets (XLH) involves administration of oral phosphate and vitamin D analogues. Newer therapies such as Anti Fibroblast Growth Factor 23 antibodies (burosumab) have now become available. An important treatment goal is to heal rickets; assessed by normalisation of serum alkaline phosphatase (ALP) levels and resolution of radiological signs of rickets.Objectives: (1) Assess disease severity ...

ea0066oc8.3 | Oral Communications 8 | BSPED2019

Specially identified patients (SIPs) – how do they work?

Rajyaguru Vipul , Tan Shin , Law James , Sachdev Pooja , Denvir Louise , Randell Tabitha

Introduction: Children with adrenal insufficiency require emergency hydrocortisone for serious illness in addition to any regular requirements. Individualised emergency plans for patients during sick days, detailing their oral and intramuscular hydrocortisone requirements, should be maintained, alongside appropriate alerts on hospital and pre-hospital systems to ensure health professionals are aware of their requirements promptly if they present acutely unwell. Following a chi...

ea0066p49 | Diabetes 5 | BSPED2019

Paediatric random glucose requests in primary care

Nicholson Benjamin , Smith Karen , Law James , Randell Tabitha , Denvir Louise , Sachdev Pooja

Background: NICE guidelines (NG18) state that paediatric patients aged <18 years old with suspected diabetes mellitus (DM) should be immediately referred to specialist care to confirm diagnosis and provide immediate treatment. The Nottingham University Hospitals (NUH) Paediatric Endocrine team advise primary care to investigate suspected hyperglycaemia using a POCT (point of care testing) glucose meter at the primary care facility to avoid the delay incurred by sending a s...

ea0039ep31 | Diabetes | BSPED2015

Comparison of current trends in obesity in patients with type 1 diabetes in Nottingham with a historical cohort and 2013–2014 national child measurement programme data in the UK

Mohamed Zainaba , Law James , Denvir Louise , Chee Carolyn , Drew Josaphine , Sachdev Pooja , Randell Tabitha

Aim: To compare the BMI z-score of children with type 1 diabetes (T1DM) in Nottingham with that of national and local background populations and to identify factors associated with increased BMI.Methods: A retrospective observational cohort study of patients with T1DM aged 2–15 years under the care of the paediatric diabetes team at Nottingham Children’s Hospital, between April 2013 and March 2014. Mean BMI-z-score for the year was com...

ea0039ep43 | Diabetes | BSPED2015

The effects of CSII on glycaemic control, hypoglycaemia, DKA and BMI in paediatric T1D patients.

Aldiss Peter , Santhanam Priyha , Kumar Kiran , Wolverson Marianne , Randell Tabitha , Denvir Louise , Sachdev Pooja

Background: Current NICE guidance states that insulin pump therapy (CSII) can be considered in Type 1 diabetes (T1DM) patients who suffer disabling hypoglycaemia in an attempt to reach glycaemic control or whose HbA1C remains high (>69 mmol/l) despite careful management on multiple daily injections (MDI).Aims: Our aims were to determine impact of CSII therapy on glycaemic control, BMI, incidence of severe hypoglycaemia and episodes of diabetic ketoac...

ea0058p013 | Gonadal | BSPED2018

Pubertal induction among girls with turner syndrome: an audit of practice from 2008–2017

Elechi Hassan Abdullahi , Law James , Benson Joanna , Dever Louise , Randell Tabitha , Sachdev Pooja

Background: Pubertal induction with incremental doses of oestrogen replacement is an important component of care offered to hypogonadal patients with Turner Syndrome (TS). Low dose oral ethinylestradiol (EE) has been extensively used in the UK but natural 17-β oestradiol (more physiological, cheaper and easily monitored in blood) is becoming increasingly popular. We undertook this audit to compare the efficacy and acceptability of oral (EE) and patch (Evorel) oestrogen pr...

ea0058p014 | Gonadal | BSPED2018

Turners syndrome – clinical presentation, genetics, investigation and management: a 10 year review

Elechi Hassan Abdullahi , Law James , Alexander Jacqui , Denvir Louise , Randell Tabitha , Sachdev Pooja

Background: Turner syndrome (TS) is characterised by a wide phenotype and age at presentation. We reviewed our over-12s Turner clinic over a period of 10 years to evaluate pattern of diagnosis, co-morbidities and management.Subjects and method: Retrospective data analysis of patients with TS who attended the over-12s clinic (2008–2017, n=28). Data is median (IQR) or mean±SD as appropriate.Result: The age at diagn...